RepliCel Life Sciences Inc. reported that effective September 1, 2015, Gemma Fetterley as VP Finance, is no longer with the company.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0428 USD | +4.99% |
|
-.--% | -4.89% |
1st Jan change | Capi. | |
---|---|---|
-4.89% | 2.78M | |
+16.38% | 122B | |
+21.33% | 116B | |
+22.18% | 27.03B | |
-21.20% | 20.36B | |
-16.89% | 16.43B | |
-18.01% | 15.91B | |
-44.74% | 15.6B | |
+61.20% | 14.94B | |
+3.35% | 13.59B |
- Stock Market
- Equities
- REPCF Stock
- News RepliCel Life Sciences Inc.
- RepliCel Life Sciences Inc. Announces Departure of Gemma Fetterley as VP Finance, Effective September 1, 2015